Israel among first to try experimental Japanese coronavirus drug
The drug is to be tested on a total of 80 patients at Hadassah, Sourasky, Poriah Hospital in Tiberias and Soroka Hospital in Beersheba, together with researchers from Hebrew University.
Tablets of Avigan (generic name : Favipiravir), a drug approved as an anti-influenza drug in Japan and developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. are displayed during a photo opportunity in Tokyo(photo credit: REUTERS)ByLAHAV HARKOV
